GOV.UK uses cookies to make the site simpler.
You’ve accepted all cookies. You can change your cookie settings at any time.
This report by the Advisory Council on the Misuse of Drugs (ACMD) investigates the impact on drug treatment.
An evaluation review of the Psychoactive Substances Bill by the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence on the 2016 drug strategy by the Advisory Council on the Misuse of Drugs (ACMD).
A review of the evidence of use and harm of Methiopropamine (MPA) by the Advisory Council on the Misuse of Drugs (ACMD).
Figures on methylphenidate base and methylphenidate hydrochloride importation between 2010 and 2012 were requested.
Information regarding various aspects of the FRANK drugs advisory service.
Request for details of the background that led to David Blunkett's decision to downgrade cannabis from a class B drug to a class C drug.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.
GOV.UK